SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-20-036661
Filing Date
2020-02-14
Accepted
2020-02-14 07:17:36
Documents
55
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q d873047d10q.htm 10-Q 933776
2 EX-31.1 d873047dex311.htm EX-31.1 9729
3 EX-31.2 d873047dex312.htm EX-31.2 9751
4 EX-32.1 d873047dex321.htm EX-32.1 4352
5 EX-32.2 d873047dex322.htm EX-32.2 4375
  Complete submission text file 0001193125-20-036661.txt   4118831

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT imvt-20191231.xml EX-101.INS 690228
7 XBRL TAXONOMY EXTENSION SCHEMA imvt-20191231.xsd EX-101.SCH 38613
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE imvt-20191231_cal.xml EX-101.CAL 32377
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE imvt-20191231_def.xml EX-101.DEF 231592
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE imvt-20191231_lab.xml EX-101.LAB 323700
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imvt-20191231_pre.xml EX-101.PRE 283637
Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Filer) CIK: 0001764013 (see all company filings)

IRS No.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-38906 | Film No.: 20613856
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences